Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC4 | O15439 | 3/20 | 1.00 |
| ▸ | ABCC1 | P33527 | 2/20 | 1.00 |
| ▸ | STS | P08842 | 3/20 | 0.83 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.83 |
| ▸ | LMNA | P02545 | 5/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.77 |
| ▸ | ESR1 | P03372 | 5/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.74 |
| ▸ | PGR | P06401 | 2/20 | 0.74 |
| ▸ | AR | P10275 | 2/20 | 0.74 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.74 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.74 |
| ▸ | ATM | Q13315 | 2/20 | 0.74 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.74 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.74 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.74 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.69 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.69 |
| ▸ | TSHR | P16473 | 2/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29392632 | 1.00 | ABCC4 (1.00) | ABCC4ABCC1STSKDM4ELMNA | |
| SCHEMBL30471686 | 1.00 | ABCC4 (1.00) | ABCC4ABCC1STSKDM4ELMNA | |
| SCHEMBL232797 | 1.00 | ABCC4 (1.00) | ABCC4ABCC1STSKDM4ELMNA | |
| E2Mate SCHEMBL5151234 | 0.91 | STS (1.00) | ABCC4ABCC1STSKDM4ELMNA | |
| E2Mate SCHEMBL5165269 | 0.91 | STS (1.00) | ABCC4ABCC1STSKDM4ELMNA | |
| SCHEMBL2291502 | 0.91 | KDM4E (1.00) | ABCC4ABCC1STSKDM4ELMNA | |
| SCHEMBL19121776 | 0.91 | ABCC4 (0.83) | ABCC4ABCC1STSKDM4ELMNA | |
| SCHEMBL21033841 | 0.91 | ABCC4 (0.83) | ABCC4ABCC1STSKDM4ELMNA | |
| SCHEMBL20634998 | 0.91 | ABCC4 (0.83) | ABCC4ABCC1STSKDM4ELMNA | |
| SCHEMBL4966962 | 0.91 | KDM4E (1.00) | ABCC4ABCC1STSKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 736 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117789993-B | Establishment and application of gastric cancer prediction model based on tongue fur metabolite | 浙江省肿瘤医院 | 2024-06-11 | — | — | CN | claimed |
| CN-118005192-A | Method for improving sewage treatment effect by storing carbon source through diatomite symbiotic particles | 重庆大学 | 2024-05-10 | — | — | CN | claimed |
| CN-117789993-A | Establishment and application of gastric cancer prediction model based on tongue fur metabolite | 浙江省肿瘤医院 | 2024-03-29 | — | — | CN | claimed |
| EP-4079308-A1 | MASS SPECTROMETRY ASSAY FOR ESTROGENIC COMPOUNDS | Quest Diagnostics Investments Incorporated (US) | 2022-10-26 | — | — | EP | claimed |
| US-10837971-B2 | Mass spectrometry assay for estrogenic compounds during hormone replacement therapy | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) | 2020-11-17 | — | — | US | claimed |
| EP-2807482-B1 | ANALYSIS OF ESTRADIOL AND ANALYTES WITH PHENOLIC OH USING LABELING CHEMISTRY AND LC-MSMS WORKFLOW | DH TECHNOLOGIES DEV PTE LTD (SG) | 2018-03-14 | — | — | EP | claimed |
| US-9874575-B2 | Analysis of estradiol and analytes with phenolic OH using labeling chemistry and LC-MSMS workflow | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2018-01-23 | — | — | US | claimed |
| CN-104040332-B | There is phenol system OH estradiol and analyte using mark chemistry and LC MSMS workflow analysis | DH科技发展私人贸易有限公司 | 2017-10-20 | — | — | CN | claimed |
| US-20160377636-A1 | MASS SPECTROMETRY ASSAY FOR ESTROGENIC COMPOUNDS | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED | 2016-12-29 | — | — | US | claimed |
| EP-2317995-B1 | INHBITORS OF MRP4 AND AGENTS STIMULATING MRP4 ACTIVITY FOR THE TREATMENT OF CARDIAC DISORDERS | INSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE) (FR) | 2016-12-07 | — | — | EP | claimed |
| WO-2006094028-A1 | COMBINAION THERAPY FOR TOPICAL APPLICATION IN THE TREATMENT OF DRY EYE SYNDROME | NASCENT PHARMACEUTICALS, INC. (US) | 2006-09-08 | — | — | WO | claimed |
| US-20060111334-A1 | Oral solid dosage forms containing a low dose of estradiol | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2006-05-25 | — | — | US | claimed |
| WO-2006053150-A2 | PHARMACEUTICAL COMPOSITIONS FOR TOPICAL APPLICATION ON THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OCULAR HYPERTENSION | NASCENT PHARMACEUTICALS, INC. (US) | 2006-05-18 | — | — | WO | claimed |
| WO-2006048261-A2 | ORAL SOLID DOSAGE FORMS CONTAINING A LOW DOSE OF ESTRADIOL | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2006-05-11 | — | — | WO | claimed |
| EP-1549292-A2 | PHARMACEUTICAL PREPARATIONS, USE OF SAID PREPARATIONS AND METHOD FOR INCREASING THE BIOAVAILABILITY OF MEDICAMENTS FOR PERORAL ADMINISTRATION | Schering Aktiengesellschaft (DE) | 2005-07-06 | — | — | EP | claimed |
| US-20040223983-A1 | Pharmaceutical preparations, use of these preparations and process for increasing the biovailability of pharmaceutical substances to be administered perorally | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2004-11-11 | — | — | US | claimed |
| WO-2004032897-A2 | PHARMACEUTICAL PREPARATIONS, USE OF SAID PREPARATIONS AND METHOD FOR INCREASING THE BIOAVAILABILITY OF MEDICAMENTS FOR PERORAL ADMINISTRATION | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-04-22 | — | — | WO | claimed |
| CN-1119929-C | Pig embryo regulation factor and its preparing process and application | XU LIREN (CN) | 2003-09-03 | — | — | CN | claimed |
| EP-0652754-B1 | DRUGS FOR TOPICAL APPLICATION OF SEX STEROIDS IN THE TREATMENT OF DRY EYE SYNDROME, AND METHODS OF PREPARATION AND APPLICATION | LUBKIN VIRGINIA (US) | 2003-03-12 | — | — | EP | claimed |
| US-5830767-A | WICKING CORE AND SHEATH | AT POINT BIO (US) | 1998-11-03 | — | — | US | claimed |